FDA Inspection 1251977 — Aspen Biopharma Labs Pvt., Ltd.
The FDA completed an inspection of Aspen Biopharma Labs Pvt., Ltd. on September 21, 2024 in Medchal Malkajgiri. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- September 21, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Medchal Malkajgiri (India)